29,596 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Acquired by QSV Equity Investors LLC

QSV Equity Investors LLC bought a new position in Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 29,596 shares of the company’s stock, valued at approximately $1,715,000. Astrana Health comprises approximately 1.6% of QSV Equity Investors LLC’s investment portfolio, making the stock its 22nd biggest position. QSV Equity Investors LLC owned approximately 0.05% of Astrana Health at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. FMR LLC acquired a new position in shares of Astrana Health during the third quarter worth approximately $48,413,000. SteelPeak Wealth LLC acquired a new position in shares of Astrana Health during the third quarter worth approximately $39,398,000. Loomis Sayles & Co. L P acquired a new position in shares of Astrana Health during the third quarter worth approximately $30,251,000. NorthCrest Asset Manangement LLC acquired a new position in shares of Astrana Health during the third quarter worth approximately $26,704,000. Finally, Charles Schwab Investment Management Inc. acquired a new position in shares of Astrana Health during the third quarter worth approximately $25,945,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of NASDAQ ASTH opened at $43.42 on Thursday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The business has a fifty day simple moving average of $52.05 and a 200 day simple moving average of $48.05. Astrana Health, Inc. has a one year low of $32.32 and a one year high of $63.20. The firm has a market capitalization of $2.44 billion, a price-to-earnings ratio of 33.40, a PEG ratio of 2.09 and a beta of 1.13.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. During the same period in the prior year, the company posted $0.47 earnings per share. Sell-side analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ASTH. TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price target for the company. BTIG Research upped their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Truist Financial upped their price target on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Friday, August 9th. KeyCorp initiated coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, Robert W. Baird upped their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $65.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.